Zylox-Tonbridge Executes HKD 1.15 Million Share Buyback, Boosts Treasury Stock to 8.35 Million Shares

Bulletin Express

Apr 17

Zylox-Tonbridge Medical Technology Co., Ltd. disclosed a repurchase of 48,000 H-shares on 17 April 2026 via the Hong Kong Stock Exchange. The repurchase was executed at prices ranging between HKD 23.54 and HKD 24.06 per share, translating into a volume-weighted average cost of HKD 23.88 and an aggregate consideration of approximately HKD 1.15 million.

Following the transaction, issued shares (excluding treasury shares) decreased to 327.99 million, down 0.0143% from the previous day’s 328.05 million. Treasury shares rose correspondingly to 8.35 million, while total issued shares remained unchanged at 336.35 million.

The buyback forms part of the mandate approved on 30 May 2025 that authorises repurchases of up to 31.96 million shares. To date, Zylox-Tonbridge has repurchased 5.53 million shares under this mandate, representing 1.69% of the company’s issued share capital on the authorisation date.

Under Hong Kong listing rules, the company is subject to a moratorium on new share issues or treasury-share sales until 17 May 2026, 30 days after the latest repurchase. All repurchases have been confirmed as compliant with the Main Board Rules and the previously filed explanatory statement.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1165930638"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1165930638\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1165930638?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-17 19:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1165930638","market":"hk","top_or_hot":-1,"title":"Zylox-Tonbridge Executes HKD 1.15 Million Share Buyback, Boosts Treasury Stock to 8.35 Million Shares","media":"Bulletin Express","content":"<p>Zylox-Tonbridge Medical Technology Co., Ltd. disclosed a repurchase of 48,000 H-shares on 17 April 2026 via the Hong Kong Stock Exchange. The repurchase was executed at prices ranging between HKD 23.54 and HKD 24.06 per share, translating into a volume-weighted average cost of HKD 23.88 and an aggregate consideration of approximately HKD 1.15 million.</p>\n<p>Following the transaction, issued shares (excluding treasury shares) decreased to 327.99 million, down 0.0143% from the previous day’s 328.05 million. Treasury shares rose correspondingly to 8.35 million, while total issued shares remained unchanged at 336.35 million.</p>\n<p>The buyback forms part of the mandate approved on 30 May 2025 that authorises repurchases of up to 31.96 million shares. To date, Zylox-Tonbridge has repurchased 5.53 million shares under this mandate, representing 1.69% of the company’s issued share capital on the authorisation date.</p>\n<p>Under Hong Kong listing rules, the company is subject to a moratorium on new share issues or treasury-share sales until 17 May 2026, 30 days after the latest repurchase. All repurchases have been confirmed as compliant with the Main Board Rules and the previously filed explanatory statement.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Zylox-Tonbridge Executes HKD 1.15 Million Share Buyback, Boosts Treasury Stock to 8.35 Million Shares</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nZylox-Tonbridge Executes HKD 1.15 Million Share Buyback, Boosts Treasury Stock to 8.35 Million Shares\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-04-17 19:03</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Zylox-Tonbridge Medical Technology Co., Ltd. disclosed a repurchase of 48,000 H-shares on 17 April 2026 via the Hong Kong Stock Exchange. The repurchase was executed at prices ranging between HKD 23.54 and HKD 24.06 per share, translating into a volume-weighted average cost of HKD 23.88 and an aggregate consideration of approximately HKD 1.15 million.</p>\n<p>Following the transaction, issued shares (excluding treasury shares) decreased to 327.99 million, down 0.0143% from the previous day’s 328.05 million. Treasury shares rose correspondingly to 8.35 million, while total issued shares remained unchanged at 336.35 million.</p>\n<p>The buyback forms part of the mandate approved on 30 May 2025 that authorises repurchases of up to 31.96 million shares. To date, Zylox-Tonbridge has repurchased 5.53 million shares under this mandate, representing 1.69% of the company’s issued share capital on the authorisation date.</p>\n<p>Under Hong Kong listing rules, the company is subject to a moratorium on new share issues or treasury-share sales until 17 May 2026, 30 days after the latest repurchase. All repurchases have been confirmed as compliant with the Main Board Rules and the previously filed explanatory statement.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02190","symbol_name":"归创通桥","start_time":0,"source_url":"","article_id":"1165930638","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1165930638","pubTimestamp":1776423795,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Zylox-Tonbridge Medical Technology Co., Ltd. disclosed a repurchase of 48,000 H-shares on 17 April 2026 via the Hong Kong Stock Exchange. The repurchase was executed at prices ranging between HKD...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02190":"归创通桥"},"translate_title":"Zylox-Tonbridge执行115万港元股票回购，库存股增至835万股","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02190":1},"content_text":"Zylox-Tonbridge Medical Technology Co., Ltd. disclosed a repurchase of 48,000 H-shares on 17 April 2026 via the Hong Kong Stock Exchange. The repurchase was executed at prices ranging between HKD 23.54 and HKD 24.06 per share, translating into a volume-weighted average cost of HKD 23.88 and an aggregate consideration of approximately HKD 1.15 million.\nFollowing the transaction, issued shares (excluding treasury shares) decreased to 327.99 million, down 0.0143% from the previous day’s 328.05 million. Treasury shares rose correspondingly to 8.35 million, while total issued shares remained unchanged at 336.35 million.\nThe buyback forms part of the mandate approved on 30 May 2025 that authorises repurchases of up to 31.96 million shares. To date, Zylox-Tonbridge has repurchased 5.53 million shares under this mandate, representing 1.69% of the company’s issued share capital on the authorisation date.\nUnder Hong Kong listing rules, the company is subject to a moratorium on new share issues or treasury-share sales until 17 May 2026, 30 days after the latest repurchase. All repurchases have been confirmed as compliant with the Main Board Rules and the previously filed explanatory statement.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"shareholding,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}